Oversonic Robotics has addeFondazione ENEA Tech Biomedical and SpotInvest to its shareholder base, strengthening its push to scale cognitive humanoid robotics across industrial and healthcare settings. The Italian company said the new investors will support the development, production and deployment of RoBee, its AI-enabled humanoid robot designed to work alongside people in complex operating environments. While the transaction signals broader backing for Oversonic’s expansion plans, the company did not disclose the value of the investments or the ownership stakes acquired.
New Shareholders Back Industrial Growth
STMicroelectronics enters the company as both a semiconductor manufacturer and a potential industrial partner for the next phase of RoBee’s development. Oversonic said the group’s engineering and manufacturing expertise will help reinforce its technology roadmap and industrial execution as humanoid robots move from pilots toward wider operational use. Fondazione ENEA Tech Biomedical, meanwhile, is expected to support the company’s work on certified robotic applications for healthcare, a sector where reliability, safety and clinical relevance are central to adoption.
Broadening the Application Base
SpotInvest, an investment vehicle linked to entrepreneur Marco Setti, adds another commercial dimension to the shareholder group. Oversonic said the investor could open additional opportunities in services and process automation, including applications connected to the food industry. The deal therefore extends beyond financing, giving the company access to partners that could contribute to product development, industrialisation and routes to market in multiple sectors.
RoBee at the Centre of the Strategy
RoBee remains the focal point of Oversonic’s growth plan, with the company positioning the machine as a cognitive humanoid that can interact with workers, production equipment and other robots through AI-based technologies. Oversonic says RoBee is the first cognitive humanoid certified to operate in factories and is already deployed in Italy and other markets, while also participating in healthcare trials. The company is seeking to advance the underlying technology platform, broaden manufacturing and care-related use cases, enlarge its team and increase industrial capacity as demand for more adaptable automation develops.
Building on an Existing Ecosystem
The new investors join an ownership structure that already includes industrial and financial partners such as Comat, Datalogic and AVM SGR through its Cysero fund. That combination gives Oversonic a network spanning robotics, automation, capital and commercial expertise, which could prove important as the company seeks to convert technical progress into repeatable deployments. Chairman Fabio Puglia and Chief Executive Paolo Denti said the strategy is to create an ecosystem that links technology, industry and practical applications rather than treating the investment solely as a corporate financing event.
Targeting International Expansion
International growth, particularly in the United States, is another central objective of the transaction. Oversonic already has operational presences in Cincinnati and Los Angeles, and said it intends to deepen engagement with industrial partners, customers, investors and other strategic players in the country. The company views its Italian base as the foundation for technology and production, while identifying Europe and the United States as key markets for its next stage of scale.
The shareholder changes give Oversonic additional industrial, technological and sector-specific support as it seeks to commercialise humanoid robotics in environments where safety and integration matter as much as technical capability. For STMicroelectronics, Fondazione ENEA Tech Biomedical and SpotInvest, the investment creates a direct connection to a company working across advanced manufacturing, healthcare and service automation. Oversonic’s ability to turn that backing into large-scale deployments of RoBee will determine whether the transaction becomes a meaningful step toward its stated ambition of becoming an internationally recognised deep-tech robotics company.